Developing Microbiome Therapeutics to Improve Efficacy of Drugs and Vaccines with Stephanie Culler Persephone Biosciences TRANSCRIPT
Download PDFApr 21, 2021
Stephanie Culler PhD, Co-Founder and CEO, Persephone Biosciences describes how the microbiome, the microbes that exist in our GI tract, impacts our overall health and specifically the immune system. Their goal is to leverage the impact of a healthy microbiome to improve the effectiveness of drugs and vaccines. By...
Apr 21, 2021
Stephanie Culler PhD, Co-Founder and CEO, Persephone Biosciences describes how the microbiome, the microbes that exist in our GI tract, impacts our overall health and specifically the immune system. Their goal is to leverage the impact of a healthy microbiome to improve the effectiveness of drugs and vaccines. By...
Moving from Precision Medicine to Personalized Drugs to Fight Driver Mutations in Cancer with Usama Malik Fore Biotherapeutics TRANSCRIPT
Download PDFApr 19, 2021
Usama Malik, CEO, Fore Biotherapeutics is aiming to treat patients with rare cancer mutations with a hyper targeted precision or personalized approach by using the Fore AI-based technology platform to investigate which drugs might work best for each mutation. While most cancer companies focus only on the most prevalent...
Apr 19, 2021
Usama Malik, CEO, Fore Biotherapeutics is aiming to treat patients with rare cancer mutations with a hyper targeted precision or personalized approach by using the Fore AI-based technology platform to investigate which drugs might work best for each mutation. While most cancer companies focus only on the most prevalent...
Genomic Information of Breast Cancer Tumors Drives Precision Medicine Treatment With Dr. Bill Audeh Agendia TRANSCRIPT
Download PDFNov 25, 2020
Dr. Bill Audeh, medical oncologist and Chief Medical Officer, Agendia left his 30 year career of medical practice treating breast cancer patients to join Agendia because of the exciting opportunities for precision medicine to treat breast cancer. With technology that allows for genomic testing of the cancer tumors, it...